Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Abingworth

Latest statistics and disclosures from Abingworth's latest quarterly 13F-HR filing:

Top 5 stock holdings are AMRN, Clovis Oncology, Supernus Pharmaceuticals, ALNY, Astex Pharmaceuticals. These five stock positions account for 80.89% of Abingworth's total stock portfolio.
Added to shares of Hyperion Therapeutics.
Started new stock positions in Hyperion Therapeutics.
Reduced shares in these stocks: ALNY (-$14.62M), Clovis Oncology (-$10.46M), Astex Pharmaceuticals (-$8.79M), INCY (-$6.80M), PARD, *alexza Pharmaceuticals.
Sold out of its positions in PARD.
As of March 31, 2013, Abingworth has $162.16M in assets under management (AUM). Assets under management dropped from a total value of $175.77M to $162.16M.
Independent of market fluctuations, Abingworth was a net seller by $39.21M worth of stocks in the most recent quarter.

Ticker	Name	Portfolio Weight	Change	Share Count	Price	Last Trade
AMRN	Amarin Corporation	36.91		8087486	7.40	6.64
	Clovis Oncology	16.59	-27.00%	938730	28.66	0.00
	Supernus Pharmaceuticals	12.48		3600000	5.62	0.00
ALNY	Alnylam Pharmaceuticals	7.73	-53.00%	514053	24.37	29.75
	Astex Pharmaceuticals	7.19	-42.00%	2557320	4.56	0.00
OGXI	OncoGenex Pharmaceuticals	4.21		603740	11.31	9.87
INCY	Incyte Corporation	4.19	-50.00%	290017	23.40	20.81
ISIS	ISIS Pharmaceuticals	2.79		267578	16.93	22.47
	Zogenix	2.58		2335218	1.79	0.00
	Anthera Pharmaceuticals	1.38		3503956	0.64	0.00
EXEL	Exelixis	1.18		415000	4.62	4.65
	Hyperion Therapeutics	0.90	NEW	62500	23.41	0.00
	*alexza Pharmaceuticals	0.77		286919	4.37	0.00
CRTX	Cornerstone Therapeutics	0.37		84742	7.04	8.50
ZLCS	Zalicus	0.35		864044	0.65	0.56
AVNR	AVANIR Pharmaceuticals	0.19		112500	2.74	4.44
	Cardiome Pharma	0.11		480856	0.36	0.00
ENMD	EntreMed	0.09		70761	2.04	2.00

stockzoa